Vivos Therapeutics Inc (VVOS)
2.63
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
2.61
-0.02
(-0.76%)
After-Hours: 20:00
Vivos Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.0495 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.039 |
| June 30, 2021 | 0.0347 |
| March 31, 2021 | 0.0882 |
| December 31, 2020 | 0.0763 |
| September 30, 2020 | -0.7164 |
| June 30, 2020 | -0.6578 |
| March 31, 2020 | |
| December 31, 2019 | -1.260 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.260
Minimum
Dec 2019
0.0882
Maximum
Mar 2021
-0.1467
Average
--
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | 0.0229 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4243 |
| Asensus Surgical Inc | 0.00 |
| Senseonics Holdings Inc | 1.151 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.73M |
| Total Liabilities (Quarterly) | 10.32M |
| Shareholders Equity (Quarterly) | 0.411M |
| Current Ratio | 0.3376 |